GATSL3 inhibitors are a class of chemical compounds that specifically target the GATSL3 (GATA Zinc Finger Domain Containing Protein 3-Like) protein, which is involved in transcriptional regulation and gene expression. GATSL3 is part of a family of zinc finger proteins known for their role in binding to specific DNA sequences and influencing the transcription of genes that regulate various biological processes, such as development, differentiation, and cellular function. GATSL3 likely plays a role in modulating the expression of genes that control cell identity and developmental pathways, similar to other GATA family proteins. Inhibitors of GATSL3 are designed to interfere with its ability to bind DNA or to interact with transcriptional co-factors, thereby disrupting its regulatory role in gene expression.
The design of GATSL3 inhibitors typically focuses on identifying molecules that can selectively bind to functional regions of the protein, particularly its zinc finger domain, which is responsible for recognizing and binding to specific DNA motifs. By preventing GATSL3 from interacting with its target DNA sequences, these inhibitors alter the expression of downstream genes, leading to changes in cellular behavior and function. Structural studies of GATSL3 have provided valuable insights into its zinc finger domain and other critical regions necessary for its transcriptional activity, aiding in the development of inhibitors that specifically target this protein. Researchers use GATSL3 inhibitors to explore the role of this protein in transcriptional regulation, examining how it influences gene expression networks and contributes to broader cellular processes. These inhibitors are powerful tools for studying transcription factors and their impact on cell differentiation, development, and gene expression at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Binds to FKBP12 and the resulting complex inhibits mTORC1, which interacts with CASTOR1. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $240.00 | 7 | |
Selectively targets mTORC1 and mTORC2, leading to a downstream effect on CASTOR1 related signaling. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $160.00 $345.00 | 12 | |
An mTOR inhibitor that acts on both mTORC1 and mTORC2 complexes, influencing CASTOR1 activity indirectly. | ||||||
WYE-354 | 1062169-56-5 | sc-364652 sc-364652A | 10 mg 50 mg | $286.00 $1200.00 | ||
Targets mTORC1 and mTORC2, disrupting signaling pathways in which CASTOR1 is involved. | ||||||
KU 0063794 | 938440-64-3 | sc-361219 | 10 mg | $209.00 | ||
Dual mTORC1 and mTORC2 inhibitor, leading to an indirect effect on CASTOR1 functions. | ||||||
Palomid 529 | 914913-88-5 | sc-364563 sc-364563A | 10 mg 50 mg | $300.00 $1000.00 | ||
An inhibitor of the Akt/mTOR pathway, indirectly modulating CASTOR1. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $32.00 $128.00 | 3 | |
Inhibits PI3K and mTOR kinase activity, which are upstream of CASTOR1 in the signaling pathway. | ||||||
OSI-027 | 936890-98-1 | sc-364557 sc-364557A | 10 mg 50 mg | $428.00 $1163.00 | 1 | |
Selective ATP-competitive inhibitor of mTORC1 and mTORC2, modulating the signaling pathways including CASTOR1. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
Inhibits PI3K, leading to downregulation of the mTOR pathway, thus indirectly influencing CASTOR1. | ||||||